Vysioneer announced it raised $750,000 in an initial filing

Company

Location

About

Vysioneer is an oncology AI company. We aim to improve the clarity about tumor heterogeneity in cancer treatment with lesion-level data. Leveraging our FDA-cleared AI platform, we help pharma companies unlock lesion-level tumor characteristics to de-risk and accelerate clinical trials. Vysioneer is using the AI platform to build the world’s largest database of lesion-level drug efficacy.